166 related articles for article (PubMed ID: 30592290)
21. CREBRF promotes the proliferation of human gastric cancer cells via the AKT signaling pathway.
Han J; Zhang L; Zhang J; Jiang Q; Tong D; Wang X; Gao X; Zhao L; Huang C
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):40-45. PubMed ID: 29729692
[TBL] [Abstract][Full Text] [Related]
22. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
23. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
24. Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
Sun Y; Pan H; He Y; Hu C; Gu Y
Head Neck; 2022 Mar; 44(3):591-605. PubMed ID: 34918847
[TBL] [Abstract][Full Text] [Related]
25. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
[TBL] [Abstract][Full Text] [Related]
26. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
28. SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway.
Ren C; Zhou Z; Wang X; Hua X; Zou M; Zhang X
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):136-143. PubMed ID: 32769441
[TBL] [Abstract][Full Text] [Related]
29. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
Yin H; Zhang C; Wei Z; He W; Xu N; Xu Y; Li T; Ren K; Kuang Y; Zhu X; Yuan F; Yu H; Gou X
Cell Death Dis; 2022 Jan; 13(1):39. PubMed ID: 35013128
[TBL] [Abstract][Full Text] [Related]
30. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
31. NIMA related kinase 2 promotes gastric cancer cell proliferation
Fan WD; Chen T; Liu PJ
World J Gastroenterol; 2019 Jun; 25(23):2898-2910. PubMed ID: 31249448
[TBL] [Abstract][Full Text] [Related]
32. The role of TRPV1 ion channels in the suppression of gastric cancer development.
Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
[TBL] [Abstract][Full Text] [Related]
33. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
34. SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer.
Yang C; Hu JF; Zhan Q; Wang ZW; Li G; Pan JJ; Huang L; Liao CY; Huang Y; Tian YF; Shen BY; Chen JZ; Wang YD; Chen S
Genomics; 2021 Mar; 113(2):827-842. PubMed ID: 33515675
[TBL] [Abstract][Full Text] [Related]
35. IL‑33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway.
Huang N; Cui X; Li W; Zhang C; Liu L; Li J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760194
[TBL] [Abstract][Full Text] [Related]
36. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
[TBL] [Abstract][Full Text] [Related]
37. CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis in vitro.
Cheng X; Wang X; Wu Z; Tan S; Zhu T; Ding K
FEBS Open Bio; 2019 Jun; 9(6):1097-1108. PubMed ID: 30974047
[TBL] [Abstract][Full Text] [Related]
38. lncRNA BG981369 Inhibits Cell Proliferation, Migration, and Invasion, and Promotes Cell Apoptosis by SRY-Related High-Mobility Group Box 4 (SOX4) Signaling Pathway in Human Gastric Cancer.
Dong X; Chen R; Lin H; Lin T; Pan S
Med Sci Monit; 2018 Feb; 24():718-726. PubMed ID: 29398692
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer.
Hu W; Wei H; Li K; Li P; Lin J; Feng R
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28597490
[TBL] [Abstract][Full Text] [Related]
40. MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.
Zhang Q; Feng Y; Liu P; Yang J
Tumour Biol; 2017 Jul; 39(7):1010428317711312. PubMed ID: 28718369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
